Name: Repaglinide- Bio-X
Price: Inquiry

- Overview
  - ATP-sensitive K+ channel inhibitor; anti-diabetic drug
    
    Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Ligands of Ion Channels
    
    Alternative Name
    
    (S)-2-Ethoxy-4-[2-[[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid; AG-EE-623; Novonorm
    
    CAS Number
    
    135062-02-1
    
    Molecular Formula
    
    C27H36N2O4
    
    Molecular Weight
    
    452.59 g/mol
    
    MDL Number
    
    MFCD00906179
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Wolffenbuttel et al (1993). Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM. European Journal of Clinical Pharmacology. 45(2):113-6.
    Ampudia-Blasco et al (1994). Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects. Diabetologia. 37(7):703-7.